Scopus Biopharma Inc.
SEC CIK 1772028 · SCPS · last insider filing 2021-11-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Greenspan Ira Scott | Director · Executive Committee Chairman | filed 2020 - 2021 |
| Lamstein Joshua R | Director · Chairman | filed 2020 - 2021 |
| Hopper Paul | Director | filed 2021 - 2021 |
| Gibson Robert J | Director · Vice Chairman | filed 2020 - 2021 |
| Hofstein Raphael | Director | filed 2020 - 2020 |
| Russell Lesley | Director | filed 2020 - 2020 |
| Buckel David A. | Director | filed 2020 - 2020 |
| Weild IV David | Director | filed 2020 - 2020 |
| Battleman David S. | Director | filed 2020 - 2020 |
| Sanghrajka Ashish P | Director · President | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Horsager Alan M | See Remarks | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.